口咽部人乳头瘤病毒感染检测方法的研究进展

周潜; 尹跃平

doi:10.7619/jcmp.20211988

口咽部人乳头瘤病毒感染检测方法的研究进展

周潜^{1, 2},
尹跃平^{1, 2, ,}

1.
中国医学科学院北京协和医学院皮肤病医院, 江苏南京, 210042
2.
中国疾病预防控制中心性病控制中心, 江苏南京, 210042

基金项目:

国家级“艾滋病和病毒性肝炎等重大传染病”科技重大专项 2018ZX10101001-004-003

详细信息

通讯作者:
尹跃平, E-mail: yinyp@ncstdlc.org

中图分类号: R739.6;R373.9
计量
- 文章访问数: 366
- HTML全文浏览量: 499
- PDF下载量: 43
出版历程
- 收稿日期: 2021-05-12
- 网络出版日期: 2021-10-08
- 发布日期: 2021-08-27

Progress in detection of oropharyngeal human papillomavirus infection

ZHOU Qian^{1, 2},
YIN Yueping^{1, 2, ,}

1.
Hospital of Dermatology of Peking Union Medical College of Chinese Academy of Medical Sciences, Nanjing, Jiangsu, 210042
2.
Center for Sexually Transmitted Disease Control of Chinese Centers for Disease Control and Prevention, Nanjing, Jiangsu, 210042

摘要

摘要: 人乳头瘤病毒(HPV)是一种仅感染人类的双链DNA病毒，口咽部HPV感染可引起口腔潜在恶性疾病与头颈部鳞状细胞癌等不良后果，口咽部HPV感染的检测是早期诊断与治疗的关键。近年来，以核酸检测与免疫组化(IHC)作为检测HPV的主流方法，其他多种替代方法也得到了迅速发展。本文综述了口咽部HPV感染的不良后果与检测方法的研究进展，以期为临床应用提供参考依据。
- 人乳头瘤病毒 /
- 头颈部鳞状细胞癌 /
- 检测方法 /
- 口咽部
Abstract:
Human papillomavirus (HPV) is a double-stranded DNA virus that only infects humans. Oropharyngeal HPV infection can cause potential oral malignant diseases as well as head and neck squamous cell carcinoma and other adverse consequences. Detection of oropharyngeal HPV infection is the key to early diagnosis and treatment. In recent years, nucleic acid detection and immunohistochemistry (IHC) are the mainstream method for the HPV detection, and many alternative methods have also been rapidly developed. This article reviewed the research progress of adverse effects and detection methods of oropharyngeal HPV infection, so as to provide reference for clinical application.
- human papillomavirus /
- head and neck squamous cell carcinoma /
- detection methods /
- oropharynx

HTML全文

参考文献(46)

[1]	BRAVO I G, FÉLEZ-SÁNCHEZ M. Papillomaviruses: Viral evolution, cancer and evolutionary medicine[J]. Evol Med Public Health, 2015, 2015(1): 32-51. doi: 10.1093/emph/eov003
[2]	SCHIFFMAN M, DOORBAR J, WENTZENSEN N, et al. Carcinogenic human papillomavirus infection[J]. Nat Rev Dis Primers, 2016, 2: 16086. doi: 10.1038/nrdp.2016.86
[3]	中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国康复医学会皮肤性病委员会. 中国尖锐湿疣临床诊疗指南(2021完整版)[J]. 中国皮肤性病学杂志, 2021, 35(4): 359-374. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBFX202104001.htm
[4]	LEEMANS C R, SNIJDERS P J F, BRAKENHOFF R H. The molecular landscape of head and neck cancer[J]. Nat Rev Cancer, 2018, 18(5): 269-282. doi: 10.1038/nrc.2018.11
[5]	翟青枝, 王雪琪, 于丹, 等. 高级别宫颈上皮内瘤变患者高危型人乳头瘤病毒型别分布及其预后[J]. 中华医院感染学杂志, 2021, 31(10): 1576-1580. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY202110030.htm
[6]	KOYFMAN S A, ISMAILA N, CROOK D, et al. Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline[J]. J Clin Oncol, 2019, 37(20): 1753-1774. doi: 10.1200/JCO.18.01921
[7]	沙桐, 张伟. 氧化应激对潜在口腔恶性疾病作用的研究进展[J]. 口腔医学研究, 2021, 37(2): 109-112. https://www.cnki.com.cn/Article/CJFDTOTAL-KQYZ202102005.htm
[8]	SHANG Q, PENG J, ZHOU Y, et al. Association of human papillomavirus with oral lichen planus and oral leukoplakia: a meta-analysis[J]. J Evid Based Dent Pract, 2020, 20(4): 101485. doi: 10.1016/j.jebdp.2020.101485
[9]	DE LA COUR C D, SPERLING C D, BELMONTE F, et al. Human papillomavirus prevalence in oral potentially malignant disorders: Systematic review and meta-analysis[J]. Oral Dis, 2021, 27(3): 431-438. doi: 10.1111/odi.13322
[10]	GURIZZAN C, LORINI L, PADERNO A, et al. Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial[J]. BMC Cancer, 2021, 21(1): 561. doi: 10.1186/s12885-021-08297-3
[11]	FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. doi: 10.1002/ijc.31937
[12]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
[13]	O′SULLIVAN B, HUANG S H, SU J, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study[J]. Lancet Oncol, 2016, 17(4): 440-451. doi: 10.1016/S1470-2045(15)00560-4
[14]	张永侠, 刘明波, 黄辉, 等. 124例舌根鳞状细胞癌临床总结及预后分析[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(24): 1867-1872. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201724001.htm
[15]	STEIN A P, SAHA S, KRANINGER J L, et al. Prevalence of human papillomavirus in oropharyngeal cancer[J]. Cancer J, 2015, 21(3): 138-146. doi: 10.1097/PPO.0000000000000115
[16]	刘一戈, 张陈平. 口腔鳞状细胞癌与人乳头瘤病毒相关性在国人中的研究进展[C]//2020年全国口腔颌面-头颈肿瘤学术大会暨中华口腔医学会口腔颌面-头颈肿瘤专业委员会学术年会——创新超越、共赢未来论文集. 武汉, 2020: 374-375.
[17]	CHATURVEDI A K, GRAUBARD B I, BROUTIAN T, et al. NHANES 2009-2012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in US men[J]. Cancer Res, 2015, 75(12): 2468-2477. doi: 10.1158/0008-5472.CAN-14-2843
[18]	TABERNA M, MENA M, PAVÓN M A, et al. Human papillomavirus-related oropharyngeal cancer[J]. Ann Oncol, 2017, 28(10): 2386-2398. doi: 10.1093/annonc/mdx304
[19]	CANCER GENOME ATLAS NETWORK. Comprehensive genomic characterization of head and neck squamous cell carcinomas[J]. Nature, 2015, 517(7536): 576-582. doi: 10.1038/nature14129
[20]	TOMAIC V. Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites[J]. Cancers, 2016, 8(10): 95. doi: 10.3390/cancers8100095
[21]	JOHNSON D E, BURTNESS B, LEEMANS C R, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1): 92. doi: 10.1038/s41572-020-00224-3
[22]	PRIGGE E S, ARBYN M, VON KNEBEL DOEBERITZ M, et al. Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis[J]. Int J Cancer, 2017, 140(5): 1186-1198. doi: 10.1002/ijc.30516
[23]	BOSCOLO-RIZZO P, PAWLITA M, HOLZINGER D. From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas[J]. Cancer Treat Rev, 2016, 42: 24-29. doi: 10.1016/j.ctrv.2015.10.009
[24]	SCHACHE A G, LILOGLOU T, RISK J M, et al. Evaluation of human Papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination[J]. Clin Cancer Res, 2011, 17(19): 6262-6271. doi: 10.1158/1078-0432.CCR-11-0388
[25]	CHERNESKY M, JANG D, SCHWEIZER J, et al. HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma[J]. Papillomavirus Res Amsterdam Neth, 2018, 6: 1-5. doi: 10.1016/j.pvr.2018.05.003
[26]	NAUTA I H, RIETBERGEN M M, VAN BOKHOVEN A A J D, et al. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing[J]. Ann Oncol, 2018, 29(5): 1273-1279. doi: 10.1093/annonc/mdy060
[27]	TORRES-IBARRA L, LORINCZ A T, WHEELER C M, et al. Adjunctive testing by cytology, p16/Ki-67 dual-stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen-positive women[J]. Int J Cancer, 2021, 148(9): 2264-2273. doi: 10.1002/ijc.33414
[28]	赵艺哗, 白玉萍, 毛美玲, 等. 口咽部人乳头状瘤病毒阳性鳞状细胞癌临床病理学观察[J]. 中华病理学杂志, 2019, 48(2): 127-131. doi: 10.3760/cma.j.issn.0529-5807.2019.02.010
[29]	LEWIS J S, BEADLE B, BISHOP J A, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists[J]. Arch Pathol Lab Med, 2018, 142(5): 559-597. doi: 10.5858/arpa.2017-0286-CP
[30]	FAKHRY C, LACCHETTI C, ROOPER L M, et al. Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the college of American pathologists guideline[J]. J Clin Oncol, 2018, 36(31): 3152-3161. doi: 10.1200/JCO.18.00684
[31]	段律芳, 杜辉, 肖爱民, 等. 宫颈癌早期诊断中细胞学p16 INK4a检测的价值[J]. 中华病理学杂志, 2020, 49(8): 812-815. doi: 10.3760/cma.j.cn112151-20191203-00779
[32]	CASTELLSAGUÉX, ALEMANY L, QUER M, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients[J]. J Natl Cancer Inst, 2016, 108(6): djv403. doi: 10.1093/jnci/djv403
[33]	SCHACHE A G, LILOGLOU T, RISK J M, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma[J]. Br J Cancer, 2013, 108(6): 1332-1339. doi: 10.1038/bjc.2013.63
[34]	AUGUSTIN J, OUTH-GAUER S, MANDAVIT M, et al. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas[J]. Hum Pathol, 2018, 78: 63-71. doi: 10.1016/j.humpath.2018.04.006
[35]	JORDAN R C, LINGEN M W, PEREZ-ORDONEZ B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials[J]. Am J Surg Pathol, 2012, 36(7): 945-954. doi: 10.1097/PAS.0b013e318253a2d1
[36]	WANG H, ZHANG Y, BAI W, et al. Feasibility of immunohistochemical p16 staining in the diagnosis of human papillomavirus infection in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis[J]. Front Oncol, 2020, 10: 524928. doi: 10.3389/fonc.2020.524928
[37]	LI Z, LIU F, CHENG S, et al. Prevalence of HPV infection among 28, 457 Chinese women in Yunnan Province, southwest China[J]. Sci Rep, 2016, 6: 21039. doi: 10.1038/srep21039
[38]	ZHAO P Y, JIANG H C, LI Y, et al. Comparison of the cervista HPV HR test and luminex XMAP technology for the diagnosis of cervical intraepithelial neoplasia[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 214: 150-155. doi: 10.1016/j.ejogrb.2017.05.012
[39]	KEUNG E S, SOUERS R J, BRIDGE J A, et al. Comparative performance of high-risk human papillomavirus RNA and DNA in situ hybridization on college of American pathologists proficiency tests[J]. Arch Pathol Lab Med, 2020, 144(3): 344-349. doi: 10.5858/arpa.2019-0093-CP
[40]	RANDÉN-BRADY R, CARPÉN T, JOUHI L, et al. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer[J]. Hum Pathol, 2019, 90: 97-105. doi: 10.1016/j.humpath.2019.05.006
[41]	PAVER E C, CURRIE A M, GUPTA R, et al. Human Papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV[J]. Pathology, 2020, 52(2): 179-191. doi: 10.1016/j.pathol.2019.10.008
[42]	LANG KUHS K A, WOOD C B, WIGGLETON J, et al. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer[J]. Cancer, 2020, 126(11): 2658-2665. doi: 10.1002/cncr.32799
[43]	LANG KUHS K A, KREIMER A R, TRIVEDI S, et al. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence[J]. Cancer, 2017, 123(22): 4382-4390. doi: 10.1002/cncr.30966
[44]	BLATT S, PABST A, ZIMMER S, et al. Clinical efficacy of an antibody-based detection system for human Papilloma virus infection in oral squamous cell carcinoma[J]. Clin Oral Investig, 2021, 25(5): 2837-2843. doi: 10.1007/s00784-020-03601-0
[45]	BALACHANDRA S, KUSIN S B, LEE R, et al. Blood-based biomarkers of human papillomavirus-associated cancers: a systematic review and meta-analysis[J]. Cancer, 2021, 127(6): 850-864. doi: 10.1002/cncr.33221
[46]	BUSSU F, RAGIN C, BOSCOLO-RIZZO P, et al. HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice[J]. Head Neck, 2019, 41(4): 1104-1111. doi: 10.1002/hed.25591

施引文献

资源附件(0)

计量

文章访问数: 366
HTML全文浏览量: 499
PDF下载量: 43
被引次数: 0

口咽部人乳头瘤病毒感染检测方法的研究进展

通讯作者: 尹跃平, E-mail: yinyp@ncstdlc.org

计量

出版历程

Progress in detection of oropharyngeal human papillomavirus infection

计量

出版历程

目录

通讯作者:
尹跃平, E-mail: yinyp@ncstdlc.org